ROR1-CAR T-CELLS AS NOVEL TREATMENT STRATEGY FOR ANAPLASTIC THYROID CARCINOMA

被引：0
|
作者：
Chernyakov, D. [1 ]
Skorobohatko, O. [1 ]
Edemir, B. [2 ]
Nerger, K. [1 ]
Mueller, T. [1 ]
Binder, M. [1 ]
Trojanowicz, B. [1 ]
Lorenz, K. [1 ]
Huettelmaier, S. [3 ]
Alb, M. [1 ]
Hudecek, M. [4 ]
Dierks, C. [1 ]
机构：
[1] Univ Klinikum Halle Saale, Halle, Saale, Germany
[2] Univ Witten Herdecke, Witten, Germany
[3] Inst Mol Med, Halle, Saale, Germany
[4] Univ Klinikum Wurzburg, Wurzburg, Germany
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-ITOC9.41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P06.01
引用
下载
收藏
页码：A22 / A23
页数：2
相关论文
共 50 条
  • [31] CLINICAL-GRADE MANUFACTURING OF ROR1 CAR T CELLS USING A NOVEL VIRUS-FREE PROTOCOL
    Mestermann, K.
    Eichler, M.
    Machwirth, M.
    Kebbel, K.
    Koehl, U.
    Einsele, H.
    Mueller, C.
    Lehmann, J.
    Rasko, T.
    Lundberg, F.
    Izsvak, Z.
    Schmiedeknecht, G.
    Hudecek, M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A55 - A56
  • [32] Virus-free production of CAR T-cells for the treatment of solid tumors
    Simara, P.
    Tesarova, L.
    Koutna, I.
    HUMAN GENE THERAPY, 2019, 30 (08) : A11 - A12
  • [33] CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
    Saleh, Khalil
    Pasquier, Florence
    Bigenwald, Camille
    De Botton, Stephane
    Ribrag, Vincent
    Castilla-Llorente, Cristina
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [34] CAR T-cells targeting Aspergillus fumigatus for the treatment of invasive pulmonary aspergillosis
    Seif, M.
    Kakoschke, T. K.
    Ebel, F.
    Bellet, M. M.
    Romani, L.
    Trinks, N. I.
    Tappe, B.
    Einsele, H.
    Hudecek, M.
    Loeffler, J.
    MYCOSES, 2021, 64 : 13 - 14
  • [35] CAR T-cells targeting the kappa myeloma antigen for the treatment of multiple myeloma
    Gowrishankar, Kavitha
    Dunn, Rosanne
    Gottlieb, David
    Micklethwaite, Kenneth
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells - a completed study overview
    Lamers, Cor H. J.
    Klaver, Yarne
    Gratama, Jan W.
    Sleijfer, Stefan
    Debets, Reno
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 951 - 959
  • [37] Correction: ROR1-targeting switchable CAR-T cells for cancer therapy
    Haiyong Peng
    Thomas Nerreter
    Katrin Mestermann
    Jakob Wachter
    Jing Chang
    Michael Hudecek
    Christoph Rader
    Oncogene, 2024, 43 : 992 - 992
  • [38] Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma
    Xu, Bin
    Qin, Tingting
    Yu, Jingcheng
    Giordano, Thomas J.
    Sartor, Maureen A.
    Koenig, Ronald J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (26) : 8834 - 8845
  • [39] Naive CD4+T Cells Modified to Express a ROR1-Specific CAR Mediate Anti-Tumor Activity and Provide Superior Help to CD8+ROR1-CAR T Cells
    Hudecek, Michael
    Lupo-Stanghellini, Maria-Teresa
    Kosasih, Paula
    Bet, Jeannette
    Paszkiewicz, Paulina
    Maloney, David G.
    Jensen, Michael C.
    Rader, Christoph
    Riddell, Stanley R.
    BLOOD, 2011, 118 (21) : 294 - 294
  • [40] DCLK1 monoclonal antibody-based CAR-T cells as novel treatment strategy against multiple myeloma
    Sureban, Sripathi M.
    Berahovich, Robert
    Zhou, Hua
    Xu, Shirley
    Wu, Lijun
    Golubovskaya, Vita
    Qu, Dongfeng
    May, Randal
    Bannerman-Menson, Edwin
    Houchen, Courtney W.
    CANCER RESEARCH, 2019, 79 (13)
12345